Aller au contenu principal
Accès ouvert déclaré 2023 conference-abstract

2754 A case of JCV encephalitis in an immune-compromised patient treated with allogeneic JCV-specific cytotoxic T lymphocytes

0Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : au. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background JCV encephalitis is a rare manifestation of JC virus infection of the CNS in immunocompromised individuals. There are a few emerging treatments in this domain, including CD8+ Cytotoxic T lymphocytes grown specifically to target JCV infected cells. While there are case reports of its use in patients with PML (progressive multifocal leukoencephalopathy), studies in management of JCV encephalitis are lacking.Presentation We describe the case of a 66-year-old woman presenting with rapid cognitive decline involving multiple domains, on a background of CLL, secondary myelodysplasia and pyoderma gangrenosum managed with immunosuppression including prednisolone and mycophenolate. Further evaluation revealed atypical multifocal cortical FLAIR signal abnormalities on MRI Brain imaging, and an elevated CSF JC viral load (3245 IU/ml), leading to the diagnosis JCV encephalitis.Management Initial management was with withdrawal of immunosuppression. She subsequently underwent HLA typing and infusion of JCV specific CD8+ Cytotoxic T lymphocytes with weekly infusions over 4 weeks. On follow up at 3 months from initial presentation and at 2 weeks following treatment completion, the CSF JC viral load had reduced significantly (223 IU/ml), inflammatory changes identified on imaging had stabilised and the deterioration in cognition had halted, however the patient remained significantly disabled.Discussion This case demonstrates the first described case of JCV encephalitis treated with Cytotoxic T lymphocytes. The outcome was radiological and virologic improvement, accompanied by clinical stabilisation within 2 weeks of treatment completion. This case highlights the importance of early recognition and potential novel treatment options for this disabling and usually fatal infection.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
2754 A case of JCV encephalitis in an immune-compromised patient treated with allogeneic JCV-specific cytotoxic T lymphocytes
Date Crossref
01/08/2023
Éditeur
BMJ Publishing Group Ltd
Type
proceedings-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Polyomavirus and related diseasesPlant Virus Research StudiesViral-associated cancers and disorders

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.